Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond One Year after Percutaneous Coronary Intervention: An Analysis from the Randomized Dual Antiplatelet Therapy Study

IMPORTANCE: Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia at the expense of increased bleeding. OBJECTIVE: To develop a clinical decision tool to identify patients expected to derive benefit vs. harm from continuing thienopyridine beyond one year after PCI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Yeh, Robert W., Secemsky, Eric A., Kereiakes, Dean J., Normand, Sharon-Lise T., Gershlick, Anthony H., Cohen, David J., Spertus, John A., Steg, Philippe Gabriel, Cutlip, Donald E., Rinaldi, Michael J., Camenzind, Edoardo, Wijns, William, Apruzzese, Patricia K., Song, Yang, Massaro, Joseph M., Mauri, Laura
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408574/
https://ncbi.nlm.nih.gov/pubmed/27022822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2016.3775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados